Glutamate-based depression GBD.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Medical Hypotheses

• Publication date

  2012-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.mehy.2012.02.009PMID 22391030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overview of glutamatergic neurotransmission in the nervous system.

  2012cited by this paper
• Efficacy and Safety of Ketamine in Patients with Complex Regional Pain Syndrome

  2012cited by this paper
• Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

  2012cited by this paper
• A systematic review of ketamine as an analgesic agent in adult burn injuries.

  2011cited by this paper
• Hox10 Genes Function in Kidney Development in the Differentiation and Integration of the Cortical Stroma

  2011cited by this paper
• TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB.

  2011cited by this paper
• The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

  2011cited by this paper
• Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression.

  2011cited by this paper
• Leukocyte Telomere Length in Major Depression: Correlations with Chronicity, Inflammation and Oxidative Stress - Preliminary Findings

  2011cited by this paper
• Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• Late-expiratory activity: emergence and interactions with the respiratory CpG.

  2010cited by this paper
• Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

  2010cited by this paper
• Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

  2010cited by this paper
• Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

  2010cited by this paper
• Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

  2010cited by this paper
• Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.

  2010cited by this paper
• Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections

  2010cited by this paper
• Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants

  2010cited by this paper
• Bidirectional neuron-glia interactions triggered by deficiency of glutamate uptake at spinal sensory synapses.

  2010cited by this paper
• Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

  2009cited by this paper
• Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis.

  2009cited by this paper
• Emerging role of glutamate in the pathophysiology of major depressive disorder.

  2009cited by this paper
• The neurobiological properties of Tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation

  2009cited by this paper
• Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

  2009cited by this paper
• Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity

  2009cited by this paper
• Excitatory amino acid transporters as potential drug targets

  2009cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008cited by this paper
• Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.

  2008cited by this paper
• The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.

  2008cited by this paper
• Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors.

  2008cited by this paper
• An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

  2008cited by this paper
• Neurobiological and Clinical Effects of the Antidepressant Tianeptine

  2008cited by this paper
• Lack of NMDA–AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test

  2008cited by this paper
• Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies.

  2007cited by this paper
• How can drug discovery for psychiatric disorders be improved?

  2007cited by this paper
• Acute stress‐mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment

  2007cited by this paper
• Gender differences in depression and chronic pain conditions in a national epidemiologic survey.

  2007cited by this paper
• Gliogenesis and glial pathology in depression.

  2007cited by this paper
• Psychopathology in verified Huntington's disease gene carriers.

  2007cited by this paper
• Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors.

  2007cited by this paper
• Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

  2007cited by this paper
• Does treating depression improve survival after acute coronary syndrome?

  2007cited by this paper
• Increased levels of glutamate in brains from patients with mood disorders.

  2007cited by this paper
• Astrocyte metabolism and signaling during brain ischemia

  2007cited by this paper
• Sensitization, glutamate, and the link between migraine and fibromyalgia

  2007cited by this paper
• The NMDA receptor as a therapeutic target in major depressive disorder.

  2007cited by this paper
• The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

  2007cited by this paper
• Recent Evidence Linking Coronary Heart Disease and Depression

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro.

  2006cited by this paper
• Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.

  2006cited by this paper
• Glutamate receptors and pain.

  2006cited by this paper
• Comorbid Depression, Chronic Pain, and Disability in Primary Care

  2006cited by this paper
• Structural Characterization of the Intermolecular Interactions of Synapse-associated Protein-97 with the NR2B Subunit of N-Methyl-d-aspartate Receptors*

  2005cited by this paper
• TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition.

  2005cited by this paper
• TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition

  2005cited by this paper
• Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis.

  2005cited by this paper
• Deep brain stimulation for treatment-resistant depression.

  2005cited by this paper
• Mortality in Parkinson's disease and its association with dementia and depression

  2004cited by this paper
• Diabetes, depression, and quality of life: a population study.

  2004cited by this paper
• The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.

  2004cited by this paper
• Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.

  2004cited by this paper
• Riluzole inhibits retinal endothelial cell proliferation in vivo and in vitro

  2004cited by this paper
• Functional but not structural subgenual prefrontal cortex abnormalities in melancholia

  2004cited by this paper
• Astrocytic control of glutamatergic activity: astrocytes as stars of the show.

  2004cited by this paper
• Ketamine in Chronic Pain Management: An Evidence-Based Review

  2003cited by this paper
• Glutamate and Depression

  2003cited by this paper
• Suicides in persons suffering from rheumatoid arthritis.

  2003cited by this paper
• Glutamate Receptors and Parkinson’s Disease

  2003cited by this paper
• Neurotransmitter changes by interferon-alpha and therapeutic implications.

  2003cited by this paper
• Immune activation and degradation of tryptophan in coronary heart disease

  2003cited by this paper
• Glutamate and depression: clinical and preclinical studies.

  2003cited by this paper
• Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells.

  2002cited by this paper
• NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity.

  2002cited by this paper
• Glutamate receptors and persistent pain: targeting forebrain NR2B subunits.

  2002cited by this paper
• Depression in Rheumatoid Arthritis: A Systematic Review of the Literature With Meta-Analysis

  2002cited by this paper
• The burden of depression in patients with rheumatoid arthritis.

  2001cited by this paper
• Relief of Fibromyalgia Symptoms following Discontinuation of Dietary Excitotoxins

  2001cited by this paper
• Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

  2000cited by this paper
• Cytokine Effects on Glutamate Uptake by Human Astrocytes

  2000cited by this paper
• Differential limbic--cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders.

  2000cited by this paper
• Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

  2000cited by this paper
• Suicidal ideation in patients with rheumatoid arthritis

  2000cited by this paper
• Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis

  2000cited by this paper
• Treatment of acute ischemic stroke.

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Effects of NMDA antagonists on ethanol-withdrawal induced "anxiety" in the elevated plus maze.

  1999cited by this paper
• Antidepressants for the new millennium.

  1999cited by this paper
• Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues.

  1998cited by this paper
• Glial reduction in the subgenual prefrontal cortex in mood disorders.

  1998cited by this paper
• Major and minor depression in Alzheimer's disease: prevalence and impact.

  1997cited by this paper
• Duration of glutamate release after acute ischemic stroke.

  1997cited by this paper
• Poststroke depression: an examination of the literature.

  1997cited by this paper
• Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntington's Disease—An In Situ Hybridization Study

  1997cited by this paper
• Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness.

  1996cited by this paper
• Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity

  1996cited by this paper
• Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

  1995cited by this paper
• Effect of Acute Stress on Hippocampal Glutamate Levels and Spectrin Proteolysis in Young and Aged Rats

  1995cited by this paper
• Massive persistent release of excitatory amino acids following human occlusive stroke.

  1995cited by this paper

• Streptomyces rimosus-inoculated soil exposure modulates metabolomic profiles under chronic stress

  2025cites this paper
• Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports

  2025cites this paper
• Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists.

  2025cites this paper
• Unveiling new secrets in Parkinson's disease: the glycatome.

  2023cites this paper
• An enriched environment improves long-term functional outcomes in mice after intracerebral hemorrhage by mechanisms that involve the Nrf2/BDNF/glutaminase pathway

  2023cites this paper
• Functional connectivity and glutamate levels of the medial prefrontal cortex in schizotypy are related to sensory amplification in a probabilistic reasoning task

  2023cites this paper
• Enriched environment protects against depressive and anxiety-like behaviors in mice after striatal intracerebral hemorrhage

  2022cites this paper
• Is depression the missing link between inflammatory mediators and cancer?

  2022cites this paper
• Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

  2022cites this paper
• Blood Glutamate Scavenging With Pyruvate as a Novel Preventative and Therapeutic Approach for Depressive-Like Behavior Following Traumatic Brain Injury in a Rat Model

  2022cites this paper
• Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

  2021cites this paper
• Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder

  2021cites this paper
• Real-time detection and imaging of exogenous and endogenous Zn2+ in the PC12 cell model of depression with a NIR fluorescent probe.

  2021cites this paper
• Simultaneous Fluorescence Imaging Reveals NMDA Receptor Dependent Zn2+/H+ Flux in the Brains of Mice with Depression.

  2020cites this paper
• The potential for metabolomics in the study and treatment of major depressive disorder and related conditions

  2020cites this paper
• Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression

  2020cites this paper
• Stereoselective Synthesis of New (2S,3R)-3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid Analogues Utilizing a C(sp3)-H Activation Strategy and Structure-Activity Relationship Studies at the Ionotropic Glutamate Receptors.

  2020cites this paper
• Modulation of DNA Methylation and Gene Expression in Rodent Cortical Neuroplasticity Pathways Exerts Rapid Antidepressant-Like Effects

  2020cites this paper
• Brain NMDA Receptors in Schizophrenia and Depression

  2020cites this paper
• The Role of Cognitive Distortions in the Longitudinal Relationship Between Problematic Drinking and Depressive Symptoms

  2019influential citation
• Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach

  2019cites this paper
• Serum Levels of Tumor Necrosis Factor-α and Loudness Dependence of Auditory Evoked Potentials at Pretreatment and Posttreatment in Patients with Major Depressive Disorder

  2019cites this paper
• Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review

  2018cites this paper
• Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer

  2018cites this paper
• Positive correlation between rat brain glutamate concentrations and mitochondrial 2-oxoglutarate dehydrogenase activity.

  2018cites this paper
• Gene expression related to serotonergic and glutamatergic neurotransmission is altered in the flinders sensitive line rat model of depression: Effect of ketamine

  2017cites this paper
• The combination of plasma glutamate and physical impairment after acute stroke as a potential indicator for the early-onset post-stroke depression.

  2017cites this paper
• Long-term outcome of perinatal stress : targeting the oxytocinergic system in the early prevention of stress-related disorders

  2016cites this paper
• Depressive Disorders: Prevalence, Costs, and Theories

  2016cites this paper
• The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression.

  2016cites this paper
• Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease

  2016cites this paper
• Emerging roles of system antiporter and its inhibition in CNS disorders

  2015cites this paper
• Structure − Activity Relationship Study of Ionotropic Glutamate Receptor Antagonist ( 2 S , 3 R ) ‐ 3-( 3-Carboxyphenyl ) pyrrolidine-2-carboxylic Acid

  2015cites this paper
• Effect of multiple intravenous doses of lanicemine (AZD6765) on the pharmacokinetics of midazolam in healthy subjects

  2015cites this paper
• Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish

  2015cites this paper
• Glutamate neurotoxicity, transport and alternate splicing of transporters

  2014cites this paper
• Treatment of Somatoform Disorders and Other Somatic Symptom Conditions (Pain, Fatigue, Hot Flashes, and Pruritus)

  2014cites this paper
• Therapeutic potential of targeting glutamate receptors in Parkinson’s disease

  2014cites this paper
• The Effects of Antidepressant Treatment in Prenatally Stressed Rats Support the Glutamatergic Hypothesis of Stress-Related Disorders

  2014cites this paper
• The Neurobiological Pathogenesis of Poststroke Depression

  2014cites this paper
• Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder

  2013cites this paper
• Pharmacological Management of Depression in Patients with Cancer: Practical Considerations

  2013cites this paper
• Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder

  2013cites this paper
• Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction

  2013cites this paper
• Neuroimaging Approaches to the Understanding of Depression and the Identification of Novel Antidepressants

  2013cites this paper
• Mediators of synaptic activity in anxiety- and depression-related behaviors

  2012cites this paper
• Alterations of the Monoaminergic Systems in the Rat Brain by Sustained Administration of Carisbamate and Lamotrigine

  2012cites this paper
• Glutamate hypothesis of depression and its consequences for antidepressant treatments

  2012cites this paper